H โ€” Medical ResearchEIN: 862610819ยท Ruling Year: 2021

Jed Ian Taxel Foundation For Rare Cancer Research Inc

Park City, Utah

CHealth Score
35C

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Below Average

๐Ÿ’ฐ
$274K
Total Revenue
๐Ÿ“Š
$288K
Total Expenses
๐Ÿฆ
$199K
Net Assets
๐Ÿ“‹
$40K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
-24.2%
Year-over-year change (2022 โ†’ 2023)
Net Margin
-5.3%
Revenue minus expenses as % of revenue
Working Capital Ratio
0.69
Net assets divided by total expenses
Liabilities-to-Assets
16.8%
Total liabilities as % of total assets

Filing History

3 filings on record
YearRevenueExpensesAssets
2023$273,837โ†“24%$288,471โ†“33%$239,577โ†“8%
2022$361,490$430,447โ†‘475%$259,183โ†“10%
2021$362,689$74,844$287,845

Frequently Asked Questions

What does Jed Ian Taxel Foundation For Rare Cancer Research Inc do?โ–ผ

Jed Ian Taxel Foundation For Rare Cancer Research Inc is a medical research nonprofit organization based in Utah. It is classified under NTEE code H30 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Jed Ian Taxel Foundation For Rare Cancer Research Inc financially healthy?โ–ผ

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Jed Ian Taxel Foundation For Rare Cancer Research Inc.

How much revenue does Jed Ian Taxel Foundation For Rare Cancer Research Inc generate?โ–ผ

Jed Ian Taxel Foundation For Rare Cancer Research Inc reports $309K in annual revenue and holds $149K in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in Utah.

Jed Ian Taxel Foundation For Rare Cancer Research Inc โ€” Park City, UT | GiveScope